{"log_id": 7595792838886232082, "direction": 0, "words_result_num": 52, "words_result": [{"probability": {"variance": 7e-05, "average": 0.991558, "min": 0.975576}, "location": {"width": 274, "top": 180, "height": 25, "left": 216}, "words": "准日期:2006年10月16日"}, {"probability": {"variance": 0.032497, "average": 0.703561, "min": 0.397451}, "location": {"width": 262, "top": 210, "height": 38, "left": 216}, "words": "修改期122月o"}, {"probability": {"variance": 1e-06, "average": 0.997113, "min": 0.99581}, "location": {"width": 100, "top": 260, "height": 31, "left": 1359}, "words": "注册商标"}, {"probability": {"variance": 0.000149, "average": 0.994385, "min": 0.944074}, "location": {"width": 708, "top": 342, "height": 43, "left": 534}, "words": "重组人促红素注射液(CHO细胞)说明书"}, {"probability": {"variance": 0.00899, "average": 0.92827, "min": 0.71436}, "location": {"width": 354, "top": 411, "height": 27, "left": 682}, "words": "仃阅读说明书井在医指导下使用"}, {"probability": {"variance": 0, "average": 0.999236, "min": 0.998193}, "location": {"width": 150, "top": 488, "height": 29, "left": 221}, "words": "【药品名称】"}, {"probability": {"variance": 0.000492, "average": 0.98851, "min": 0.897992}, "location": {"width": 516, "top": 523, "height": 34, "left": 212}, "words": "通用名称:重组人促红素注射液(CHO细胞"}, {"probability": {"variance": 0.001376, "average": 0.968714, "min": 0.865984}, "location": {"width": 769, "top": 559, "height": 36, "left": 214}, "words": "英文名称: Recombinan. Human Erythropoietin Injection( CHO cell'"}, {"probability": {"variance": 0.001128, "average": 0.976973, "min": 0.873568}, "location": {"width": 676, "top": 591, "height": 41, "left": 212}, "words": "汉语拼音: Chongzu Ren Cuhongsu Zhusheye( CHO Xibao)"}, {"probability": {"variance": 4.5e-05, "average": 0.980503, "min": 0.969221}, "location": {"width": 102, "top": 630, "height": 34, "left": 221}, "words": "【成份】"}, {"probability": {"variance": 0.009041, "average": 0.96203, "min": 0.386593}, "location": {"width": 1269, "top": 666, "height": 43, "left": 212}, "words": "活性成份:重组人促红素,系由含有高效表达人红细胞生成素(简称人促红素)基因的中国仓鼠卵巢(CHO"}, {"probability": {"variance": 7.4e-05, "average": 0.99231, "min": 0.966972}, "location": {"width": 497, "top": 703, "height": 34, "left": 212}, "words": "胞,经细胞培养、分离和高度纯化后制成"}, {"probability": {"variance": 0.014838, "average": 0.941103, "min": 0.565677}, "location": {"width": 637, "top": 737, "height": 36, "left": 212}, "words": "药用料:人血白蛋白、桕橼酸、杓橼酸钠、氯化钠"}, {"probability": {"variance": 0, "average": 0.99971, "min": 0.99949}, "location": {"width": 98, "top": 774, "height": 31, "left": 216}, "words": "【性状"}, {"probability": {"variance": 0.028438, "average": 0.86671, "min": 0.474542}, "location": {"width": 541, "top": 744, "height": 66, "left": 927}, "words": "受理号B080028"}, {"probability": {"variance": 0.000201, "average": 0.990301, "min": 0.955773}, "location": {"width": 223, "top": 808, "height": 34, "left": 212}, "words": "应为无色澄明液体"}, {"probability": {"variance": 0.00014, "average": 0.990213, "min": 0.975099}, "location": {"width": 125, "top": 845, "height": 31, "left": 216}, "words": "【适应症】"}, {"probability": {"variance": 0.027227, "average": 0.905052, "min": 0.390528}, "location": {"width": 1123, "top": 849, "height": 84, "left": 207}, "words": "肾功能不全所致的贫血,包括慢性肾功能衰竭行血液透析格疗和非透析是药高监静"}, {"probability": {"variance": 0.000537, "average": 0.983279, "min": 0.943342}, "location": {"width": 89, "top": 918, "height": 31, "left": 223}, "words": "【规格】"}, {"probability": {"variance": 0.027885, "average": 0.889588, "min": 0.489233}, "location": {"width": 509, "top": 909, "height": 52, "left": 927}, "words": "收到备料安,请按SFDA2执"}, {"probability": {"variance": 0.011945, "average": 0.929199, "min": 0.614084}, "location": {"width": 443, "top": 952, "height": 31, "left": 210}, "words": "2000IU/1.0ml/支、3000IU/1.0ml/支"}, {"probability": {"variance": 0.000273, "average": 0.982947, "min": 0.953245}, "location": {"width": 143, "top": 991, "height": 29, "left": 223}, "words": "【用法用量】"}, {"probability": {"variance": 0.052405, "average": 0.833406, "min": 0.395714}, "location": {"width": 415, "top": 915, "height": 109, "left": 1066}, "words": "药品注受理查专用章人务"}, {"probability": {"variance": 0.012957, "average": 0.954105, "min": 0.39258}, "location": {"width": 1256, "top": 1018, "height": 52, "left": 262}, "words": "本品应在医师指导下使用,可皮下注射或静脉注射,每周分2~3次给药药量依据病人的贫血程"}, {"probability": {"variance": 0.004019, "average": 0.979088, "min": 0.690116}, "location": {"width": 721, "top": 1055, "height": 43, "left": 207}, "words": "度、年龄及共他相关因素调整,以下为一般治疗的推荐方案"}, {"probability": {"variance": 0.011447, "average": 0.935786, "min": 0.529519}, "location": {"width": 1308, "top": 1094, "height": 43, "left": 207}, "words": "1治疗期:开始推荐剂量血液透析患者每周100~150IU/kg体重,非透析病人每周75~100IU/kg体重。若发"}, {"probability": {"variance": 0.020582, "average": 0.931211, "min": 0.404024}, "location": {"width": 1285, "top": 1132, "height": 38, "left": 210}, "words": "现红细胞压积增加不理想(每周增加少于0.5Yo1%),可于4周后按15~30IU/kg体重增加剂量,但最高"}, {"probability": {"variance": 0.014146, "average": 0.944807, "min": 0.377407}, "location": {"width": 1078, "top": 1169, "height": 34, "left": 207}, "words": "加剂量不可超过30IU/kg体重/周。红细胞压积应增加到3033yo1%,但不宜超过34v1%"}, {"probability": {"variance": 0.008894, "average": 0.963149, "min": 0.379278}, "location": {"width": 1308, "top": 1203, "height": 43, "left": 205}, "words": "2.维持期:如果红细胞压积达到30~-301%或/和血红蛋白达到100~110g/L,则进入维持治疗阶。推荐将"}, {"probability": {"variance": 0.010601, "average": 0.9607, "min": 0.51809}, "location": {"width": 1299, "top": 1240, "height": 43, "left": 207}, "words": "剂量调整至治疗期剂量的2/3,然后每2~4周检查红细胞压积以调整剂量,避免红细胞生成过速,维持红细"}, {"probability": {"variance": 0.000763, "average": 0.987828, "min": 0.89472}, "location": {"width": 363, "top": 1276, "height": 34, "left": 205}, "words": "胞压积和血红蛋白在适当水平"}, {"probability": {"variance": 0.000446, "average": 0.991238, "min": 0.897336}, "location": {"width": 856, "top": 1313, "height": 36, "left": 260}, "words": "重组人促红素一般需长期维持使用。但有特殊情况,可以随时终止治疗"}, {"probability": {"variance": 5.1e-05, "average": 0.995863, "min": 0.979934}, "location": {"width": 148, "top": 1349, "height": 29, "left": 214}, "words": "【不良反应】"}, {"probability": {"variance": 0.001618, "average": 0.985854, "min": 0.742751}, "location": {"width": 1308, "top": 1384, "height": 41, "left": 203}, "words": "1.一般反应:少数病人用药初期可出现头疼、低热、乏力等,个别病人可出现肌痛、关节痛等。绝大多数不良"}, {"probability": {"variance": 0.00118, "average": 0.989386, "min": 0.781216}, "location": {"width": 1107, "top": 1420, "height": 38, "left": 203}, "words": "反应经对症处理后可以好转,不影响继续用药,极个别病例上述症状持续存在,应考虑停药"}, {"probability": {"variance": 0.013728, "average": 0.962204, "min": 0.351966}, "location": {"width": 1299, "top": 1454, "height": 45, "left": 198}, "words": "2.过敏反应;极少数患者用药后可能出现皮或荨麻疹等过敏反应,包括过敏性休克。因此,初次使用本品"}, {"probability": {"variance": 0.004138, "average": 0.982359, "min": 0.592936}, "location": {"width": 1295, "top": 1491, "height": 43, "left": 203}, "words": "或重新使用本品时,建议先使用少量,确定无异常反应后,再注射全量,如发现异常,应立即停药井妥善处"}, {"probability": {"variance": 0.004618, "average": 0.973788, "min": 0.70148}, "location": {"width": 1297, "top": 1562, "height": 43, "left": 201}, "words": "3.心脑血管系统:用药后可能会引起血压升高、原有的高血压恶化和因高血压脑病而有头痛、意识障碍、痉"}, {"probability": {"variance": 0.012759, "average": 0.961599, "min": 0.406983}, "location": {"width": 1295, "top": 1596, "height": 47, "left": 203}, "words": "发生,甚至可引起脑出血。因此在重组人促红素注射液治疗期间应注意并定期观察血压变化,必要时应减"}, {"probability": {"variance": 2e-06, "average": 0.998468, "min": 0.995599}, "location": {"width": 390, "top": 1637, "height": 31, "left": 203}, "words": "量或停药,并调整降压药的剂量"}, {"probability": {"variance": 0.001131, "average": 0.989123, "min": 0.79823}, "location": {"width": 1027, "top": 1674, "height": 34, "left": 201}, "words": "4.血液系统:随着红细胞压积增高,血液粘度可明显增高,因此应注意防止血栓形成"}, {"probability": {"variance": 0.002303, "average": 0.974621, "min": 0.837653}, "location": {"width": 381, "top": 1708, "height": 31, "left": 198}, "words": "5.肝脏:有G0T、GPT的上升"}, {"probability": {"variance": 0.003792, "average": 0.981674, "min": 0.671926}, "location": {"width": 726, "top": 1745, "height": 34, "left": 196}, "words": "6.胃肠:有时会有恶心,呕吐、食欲不振、腹泻等情况发生"}, {"probability": {"variance": 6.7e-05, "average": 0.99205, "min": 0.978865}, "location": {"width": 93, "top": 1781, "height": 31, "left": 210}, "words": "【禁忌】"}, {"probability": {"variance": 0.010571, "average": 0.953969, "min": 0.607232}, "location": {"width": 335, "top": 1818, "height": 31, "left": 201}, "words": "1.未控制的重度高血压患者"}, {"probability": {"variance": 0.007865, "average": 0.972892, "min": 0.522783}, "location": {"width": 806, "top": 1854, "height": 36, "left": 196}, "words": "2对本品及其他喃乳动物细胞衍生物过敏者,对人血白蛋白过敏者"}, {"probability": {"variance": 0.017007, "average": 0.950222, "min": 0.525682}, "location": {"width": 502, "top": 1891, "height": 34, "left": 198}, "words": "3合并感染者,宜控制感染后再使用本品"}, {"probability": {"variance": 0.002798, "average": 0.973698, "min": 0.855592}, "location": {"width": 146, "top": 1927, "height": 29, "left": 210}, "words": "【注意事项】"}, {"probability": {"variance": 0.007683, "average": 0.961614, "min": 0.563785}, "location": {"width": 1297, "top": 1962, "height": 38, "left": 198}, "words": "1.本品用药期间应定期检查红细胞压积(用药初期每星期一次,维持期每两星期一次),注意避免过度的红细"}, {"probability": {"variance": 0.019009, "average": 0.946081, "min": 0.422267}, "location": {"width": 1167, "top": 1998, "height": 36, "left": 198}, "words": "胞生成(确认红细胞压积在34vo1%以下),如发现过度的红细胞生长,应采取时停药等适当处理"}, {"probability": {"variance": 0.015589, "average": 0.961998, "min": 0.366939}, "location": {"width": 751, "top": 2035, "height": 36, "left": 196}, "words": "2.应用本品可能会引起高血症,应停药至回复正常水平为止"}, {"probability": {"variance": 0.000685, "average": 0.988984, "min": 0.86286}, "location": {"width": 1190, "top": 2071, "height": 36, "left": 198}, "words": "3.对有心肌梗塞、肺梗塞、脑梗塞患者,有药物过敏症病史的患者及有过敏倾向的患者应慎重给药"}], "language": 3}